The high-profile trial of former Theranos CEO Elizabeth Holmes boils down to a single question: Did she cover up defects in her startup’s blood-testing technology to rip off investors while potentially endangering the lives of unwitting patients
Related posts
-
Batavia man facing federal investment fraud charges
A Batavia man is facing federal fraud charges after prosecutors said he lied to clients about... -
Obama archive in Hoffman Estates planned move to Maryland before appearance on DOGE list
The Department of Government Efficiency recently claimed to end an annual $1.48 million lease of a... -
How local skaters are coming together to honor D.C. plane crash victims
Local figure skaters on Friday will honor the 28 people killed in a plane crash after...